- AU$18.00m
- AU$14.64m
- AU$0.01m
Brief: Patrys Requests Trading Halt
Brief: Patrys Appoints Samantha South As CEO
Brief: Patrys Entered Into Agreement To Acquire Reliis
Brief: Patrys Seeks Trading Halt
Brief: Patrys Says CEO Position To Be Made Redundant
Brief: Patrys Appoints Peter Christie As Chair
Brief: Patrys Seeks Trading Halt
Australia's Patrys slumps to record low as cancer antibody fails production parameters
Australia's Patrys jumps as study validates potential of antibody
Brief: Patrys Says Total Comprehensive Loss For Half-Year Attributable A$3.9 Million
Brief: Patrys Appoints Charmaine Gittleson As Chairman
Australia's Patrys soars on positive cancer drug pre-clinical data
Brief: Patrys Says John Read Will Be Retiring As Non-Executive Chair
Australia Stock Exchange release from PATRYS : Stable Cell Line for Production of PAT-DX3 Established
Australia Stock Exchange release from PATRYS : PRE_NR Ends: 09:00:21
Australia Stock Exchange release from PATRYS : Appendix 4D - Half Year Accounts - 31 December 2021
Australia Stock Exchange release from PATRYS : PRE_NR Ends: 17:39:32
Australia Stock Exchange release from PATRYS : Application for quotation of securities - PAB
Australia Stock Exchange release from PATRYS : Appendix 4C - Quarterly - 31 December 2021